why choose us

First received: August 10, 2022

Clinical Trial: Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)

Study Status: Completed

Recruit Status: Completed

Condition: Cerebrotendinous Xanthomatoses

Study Type: Observational


Official Title: Retrospective Cohort Study to Investigate the Safety and Efficacy of Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)

Brief Summary: Retrospective study of CTX patients to investigate the safety and clinical efficacy of Chenodeoxycholic Acid

Read more